Venture capital for biotechnology companies “regained its colours” in 2012 after a drop in the previous two years, according to the trade association France Biotech.
French biotechnology companies received a combined €138 million of venture capital last year, up from €121m in 2011, according to the association’s study, Panorama of Life Sciences 2012, published on 6 June.
There has also been a sharp increase in stock-market launches, from €92m in 2011 to €146m last year. France totalled 27 successful initial public offerings in the biotechnology area, worth a combined €491m, between 2007 and 2012. In the same period, the number of launches was just six in the UK, three in Switzerland and two in Germany, says the report.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.